共 38 条
[4]
A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781
[J].
AIDS RESEARCH AND HUMAN RETROVIRUSES,
1998, 14 (03)
:255-260
[5]
BALZARINI J, 1993, MOL PHARMACOL, V43, P109
[6]
BALZARINI J, 1992, J BIOL CHEM, V267, P11831
[7]
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) STRAINS SELECTED FOR RESISTANCE AGAINST THE HIV-1-SPECIFIC [2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOLE-2'',2''-DIOXIDE)]-BETA-D-PENTOFURANOSYL (TSAO) NUCLEOSIDE ANALOGS RETAIN SENSITIVITY TO HIV-1-SPECIFIC NONNUCLEOSIDE INHIBITORS
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1993, 90 (15)
:6952-6956
[8]
Balzarini J, 1999, BIOCHEM PHARMACOL, V58, P1